NCT00603148View on ClinicalTrials.gov

The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

CompletedOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Genetic Polymorphism
Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University

OTHER

NCT00603148 - The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications | Biotech Hunter | Biotech Hunter